苏州吉美瑞生医学科技有限公司
Pioneering the future of regenerative medicine with the world’s first autologous stem cell treatment for respiratory diseases.
5 employees · est. 2015
FABPulous is the older company (2000 vs 2015).
Side-by-Side Comparison
| Metric | FABPulous | 苏州吉美瑞生医学科技有限公司 |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2015 |
| Headquarters | ||
| Headquarters | Not tracked yet | Not tracked yet |
| Employees | ||
| Employees | Not tracked yet | 5 |
| Industry | ||
| Industry | Biotechnology, Care Economy, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series B |
| Total Funding | ||
| Total Funding | $3.43M | $100.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Medical Diagnostics, Point-of-Care Testing, Emergency Medicine, Primary Care, Rapid Diagnostics, Cardiac Biomarkers, Medical Technology, Startup, Investment, Biotech, Netherlands, Maastricht University, Equity Financing, Health Innovations | Regenerative Medicine, Stem Cell Treatment, Respiratory Diseases, Autologous Stem Cells, Medical Approvals, Clinical Research, Ministry Of Science And Technology Endorsement, Quality Management System, China Healthcare Regulations, Global Leader, ISO Certification, Regulatory Compliance, Organ Regeneration, Healthcare Advancements |
| Website | ||
| Website | fabpulous.com | regend.cn |
About FABPulous
FABPulous is a pioneering healthcare company based in The Netherlands, established in 2008 as a spinoff from Maastricht University. The company secured its initial equity financing in December 2009 with key investors including Thuja Capital, Health Innovations, Limburg Ventures, and NV Industriebank...
About 苏州吉美瑞生医学科技有限公司
Suzhou Jimray Biotechnology Co., Ltd. is pioneering the future of regenerative medicine with its flagship product, REGEND001 cell preparation, the world's first autologous stem cell solution for respiratory diseases. Established in 2015, the company has received approval from the State Food and Drug...
We will tell you when either one moves
BounceWatch watches FABPulous and 苏州吉美瑞生医学科技有限公司 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at FABPulous and 苏州吉美瑞生医学科技有... — by email.
Frequently Asked Questions
Compare FABPulous with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at FABPulous on 12 Sep 2024, and 苏州吉美瑞生医学科技有限公司 on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.